Global Ibrutinib Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Ibrutinib Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Ibrutinib by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Ibrutinib by Country/Region, 2017, 2022 & 2028

2.2 Ibrutinib Segment by Type

2.2.1 90 Capsules/Box

2.2.2 120 Capsules/Box

2.3 Ibrutinib Sales by Type

2.3.1 Global Ibrutinib Sales Market Share by Type (2017-2022)

2.3.2 Global Ibrutinib Revenue and Market Share by Type (2017-2022)

2.3.3 Global Ibrutinib Sale Price by Type (2017-2022)

2.4 Ibrutinib Segment by Application

2.4.1 Mantle Cell Lymphoma

2.4.2 Chronic Lymphocytic Leukemia

2.4.3 Small Lymphocytic Lymphoma

2.4.4 Other

2.5 Ibrutinib Sales by Application

2.5.1 Global Ibrutinib Sale Market Share by Application (2017-2022)

2.5.2 Global Ibrutinib Revenue and Market Share by Application (2017-2022)

2.5.3 Global Ibrutinib Sale Price by Application (2017-2022)

3 Global Ibrutinib by Company

3.1 Global Ibrutinib Breakdown Data by Company

3.1.1 Global Ibrutinib Annual Sales by Company (2020-2022)

3.1.2 Global Ibrutinib Sales Market Share by Company (2020-2022)

3.2 Global Ibrutinib Annual Revenue by Company (2020-2022)

3.2.1 Global Ibrutinib Revenue by Company (2020-2022)

3.2.2 Global Ibrutinib Revenue Market Share by Company (2020-2022)

3.3 Global Ibrutinib Sale Price by Company

3.4 Key Manufacturers Ibrutinib Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Ibrutinib Product Location Distribution

3.4.2 Players Ibrutinib Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Ibrutinib by Geographic Region

4.1 World Historic Ibrutinib Market Size by Geographic Region (2017-2022)

4.1.1 Global Ibrutinib Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Ibrutinib Annual Revenue by Geographic Region

4.2 World Historic Ibrutinib Market Size by Country/Region (2017-2022)

4.2.1 Global Ibrutinib Annual Sales by Country/Region (2017-2022)

4.2.2 Global Ibrutinib Annual Revenue by Country/Region

4.3 Americas Ibrutinib Sales Growth

4.4 APAC Ibrutinib Sales Growth

4.5 Europe Ibrutinib Sales Growth

4.6 Middle East & Africa Ibrutinib Sales Growth

5 Americas

5.1 Americas Ibrutinib Sales by Country

5.1.1 Americas Ibrutinib Sales by Country (2017-2022)

5.1.2 Americas Ibrutinib Revenue by Country (2017-2022)

5.2 Americas Ibrutinib Sales by Type

5.3 Americas Ibrutinib Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Ibrutinib Sales by Region

6.1.1 APAC Ibrutinib Sales by Region (2017-2022)

6.1.2 APAC Ibrutinib Revenue by Region (2017-2022)

6.2 APAC Ibrutinib Sales by Type

6.3 APAC Ibrutinib Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Ibrutinib by Country

7.1.1 Europe Ibrutinib Sales by Country (2017-2022)

7.1.2 Europe Ibrutinib Revenue by Country (2017-2022)

7.2 Europe Ibrutinib Sales by Type

7.3 Europe Ibrutinib Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Ibrutinib by Country

8.1.1 Middle East & Africa Ibrutinib Sales by Country (2017-2022)

8.1.2 Middle East & Africa Ibrutinib Revenue by Country (2017-2022)

8.2 Middle East & Africa Ibrutinib Sales by Type

8.3 Middle East & Africa Ibrutinib Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Ibrutinib

10.3 Manufacturing Process Analysis of Ibrutinib

10.4 Industry Chain Structure of Ibrutinib

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Ibrutinib Distributors

11.3 Ibrutinib Customer

12 World Forecast Review for Ibrutinib by Geographic Region

12.1 Global Ibrutinib Market Size Forecast by Region

12.1.1 Global Ibrutinib Forecast by Region (2023-2028)

12.1.2 Global Ibrutinib Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Ibrutinib Forecast by Type

12.7 Global Ibrutinib Forecast by Application

13 Key Players Analysis

13.1 Beacon Pharmaceuticals

13.1.1 Beacon Pharmaceuticals Company Information

13.1.2 Beacon Pharmaceuticals Ibrutinib Product Offered

13.1.3 Beacon Pharmaceuticals Ibrutinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Beacon Pharmaceuticals Main Business Overview

13.1.5 Beacon Pharmaceuticals Latest Developments

13.2 Janssen Pharmaceuticals

13.2.1 Janssen Pharmaceuticals Company Information

13.2.2 Janssen Pharmaceuticals Ibrutinib Product Offered

13.2.3 Janssen Pharmaceuticals Ibrutinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Janssen Pharmaceuticals Main Business Overview

13.2.5 Janssen Pharmaceuticals Latest Developments

13.3 Incepta Pharmaceuticals

13.3.1 Incepta Pharmaceuticals Company Information

13.3.2 Incepta Pharmaceuticals Ibrutinib Product Offered

13.3.3 Incepta Pharmaceuticals Ibrutinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Incepta Pharmaceuticals Main Business Overview

13.3.5 Incepta Pharmaceuticals Latest Developments

13.4 Pharmacyclics Inc

13.4.1 Pharmacyclics Inc Company Information

13.4.2 Pharmacyclics Inc Ibrutinib Product Offered

13.4.3 Pharmacyclics Inc Ibrutinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Pharmacyclics Inc Main Business Overview

13.4.5 Pharmacyclics Inc Latest Developments

13.5 Bluepharma

13.5.1 Bluepharma Company Information

13.5.2 Bluepharma Ibrutinib Product Offered

13.5.3 Bluepharma Ibrutinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Bluepharma Main Business Overview

13.5.5 Bluepharma Latest Developments

13.6 Johnson & Johnson

13.6.1 Johnson & Johnson Company Information

13.6.2 Johnson & Johnson Ibrutinib Product Offered

13.6.3 Johnson & Johnson Ibrutinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Johnson & Johnson Main Business Overview

13.6.5 Johnson & Johnson Latest Developments

14 Research Findings and Conclusion

Table 1. Ibrutinib Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Ibrutinib Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 90 Capsules/Box

Table 4. Major Players of 120 Capsules/Box

Table 5. Global Ibrutinib Sales by Type (2017-2022) & (K Pcs)

Table 6. Global Ibrutinib Sales Market Share by Type (2017-2022)

Table 7. Global Ibrutinib Revenue by Type (2017-2022) & ($ million)

Table 8. Global Ibrutinib Revenue Market Share by Type (2017-2022)

Table 9. Global Ibrutinib Sale Price by Type (2017-2022) & (USD/Pcs)

Table 10. Global Ibrutinib Sales by Application (2017-2022) & (K Pcs)

Table 11. Global Ibrutinib Sales Market Share by Application (2017-2022)

Table 12. Global Ibrutinib Revenue by Application (2017-2022)

Table 13. Global Ibrutinib Revenue Market Share by Application (2017-2022)

Table 14. Global Ibrutinib Sale Price by Application (2017-2022) & (USD/Pcs)

Table 15. Global Ibrutinib Sales by Company (2020-2022) & (K Pcs)

Table 16. Global Ibrutinib Sales Market Share by Company (2020-2022)

Table 17. Global Ibrutinib Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Ibrutinib Revenue Market Share by Company (2020-2022)

Table 19. Global Ibrutinib Sale Price by Company (2020-2022) & (USD/Pcs)

Table 20. Key Manufacturers Ibrutinib Producing Area Distribution and Sales Area

Table 21. Players Ibrutinib Products Offered

Table 22. Ibrutinib Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Ibrutinib Sales by Geographic Region (2017-2022) & (K Pcs)

Table 26. Global Ibrutinib Sales Market Share Geographic Region (2017-2022)

Table 27. Global Ibrutinib Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Ibrutinib Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Ibrutinib Sales by Country/Region (2017-2022) & (K Pcs)

Table 30. Global Ibrutinib Sales Market Share by Country/Region (2017-2022)

Table 31. Global Ibrutinib Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Ibrutinib Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Ibrutinib Sales by Country (2017-2022) & (K Pcs)

Table 34. Americas Ibrutinib Sales Market Share by Country (2017-2022)

Table 35. Americas Ibrutinib Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Ibrutinib Revenue Market Share by Country (2017-2022)

Table 37. Americas Ibrutinib Sales by Type (2017-2022) & (K Pcs)

Table 38. Americas Ibrutinib Sales Market Share by Type (2017-2022)

Table 39. Americas Ibrutinib Sales by Application (2017-2022) & (K Pcs)

Table 40. Americas Ibrutinib Sales Market Share by Application (2017-2022)

Table 41. APAC Ibrutinib Sales by Region (2017-2022) & (K Pcs)

Table 42. APAC Ibrutinib Sales Market Share by Region (2017-2022)

Table 43. APAC Ibrutinib Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Ibrutinib Revenue Market Share by Region (2017-2022)

Table 45. APAC Ibrutinib Sales by Type (2017-2022) & (K Pcs)

Table 46. APAC Ibrutinib Sales Market Share by Type (2017-2022)

Table 47. APAC Ibrutinib Sales by Application (2017-2022) & (K Pcs)

Table 48. APAC Ibrutinib Sales Market Share by Application (2017-2022)

Table 49. Europe Ibrutinib Sales by Country (2017-2022) & (K Pcs)

Table 50. Europe Ibrutinib Sales Market Share by Country (2017-2022)

Table 51. Europe Ibrutinib Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Ibrutinib Revenue Market Share by Country (2017-2022)

Table 53. Europe Ibrutinib Sales by Type (2017-2022) & (K Pcs)

Table 54. Europe Ibrutinib Sales Market Share by Type (2017-2022)

Table 55. Europe Ibrutinib Sales by Application (2017-2022) & (K Pcs)

Table 56. Europe Ibrutinib Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Ibrutinib Sales by Country (2017-2022) & (K Pcs)

Table 58. Middle East & Africa Ibrutinib Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Ibrutinib Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Ibrutinib Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Ibrutinib Sales by Type (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Ibrutinib Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Ibrutinib Sales by Application (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Ibrutinib Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Ibrutinib

Table 66. Key Market Challenges & Risks of Ibrutinib

Table 67. Key Industry Trends of Ibrutinib

Table 68. Ibrutinib Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Ibrutinib Distributors List

Table 71. Ibrutinib Customer List

Table 72. Global Ibrutinib Sales Forecast by Region (2023-2028) & (K Pcs)

Table 73. Global Ibrutinib Sales Market Forecast by Region

Table 74. Global Ibrutinib Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Ibrutinib Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Ibrutinib Sales Forecast by Country (2023-2028) & (K Pcs)

Table 77. Americas Ibrutinib Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Ibrutinib Sales Forecast by Region (2023-2028) & (K Pcs)

Table 79. APAC Ibrutinib Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Ibrutinib Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Europe Ibrutinib Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Ibrutinib Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Middle East & Africa Ibrutinib Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Ibrutinib Sales Forecast by Type (2023-2028) & (K Pcs)

Table 85. Global Ibrutinib Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Ibrutinib Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Ibrutinib Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Ibrutinib Sales Forecast by Application (2023-2028) & (K Pcs)

Table 89. Global Ibrutinib Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Ibrutinib Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Ibrutinib Revenue Market Share Forecast by Application (2023-2028)

Table 92. Beacon Pharmaceuticals Basic Information, Ibrutinib Manufacturing Base, Sales Area and Its Competitors

Table 93. Beacon Pharmaceuticals Ibrutinib Product Offered

Table 94. Beacon Pharmaceuticals Ibrutinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 95. Beacon Pharmaceuticals Main Business

Table 96. Beacon Pharmaceuticals Latest Developments

Table 97. Janssen Pharmaceuticals Basic Information, Ibrutinib Manufacturing Base, Sales Area and Its Competitors

Table 98. Janssen Pharmaceuticals Ibrutinib Product Offered

Table 99. Janssen Pharmaceuticals Ibrutinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 100. Janssen Pharmaceuticals Main Business

Table 101. Janssen Pharmaceuticals Latest Developments

Table 102. Incepta Pharmaceuticals Basic Information, Ibrutinib Manufacturing Base, Sales Area and Its Competitors

Table 103. Incepta Pharmaceuticals Ibrutinib Product Offered

Table 104. Incepta Pharmaceuticals Ibrutinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 105. Incepta Pharmaceuticals Main Business

Table 106. Incepta Pharmaceuticals Latest Developments

Table 107. Pharmacyclics Inc Basic Information, Ibrutinib Manufacturing Base, Sales Area and Its Competitors

Table 108. Pharmacyclics Inc Ibrutinib Product Offered

Table 109. Pharmacyclics Inc Ibrutinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 110. Pharmacyclics Inc Main Business

Table 111. Pharmacyclics Inc Latest Developments

Table 112. Bluepharma Basic Information, Ibrutinib Manufacturing Base, Sales Area and Its Competitors

Table 113. Bluepharma Ibrutinib Product Offered

Table 114. Bluepharma Ibrutinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 115. Bluepharma Main Business

Table 116. Bluepharma Latest Developments

Table 117. Johnson & Johnson Basic Information, Ibrutinib Manufacturing Base, Sales Area and Its Competitors

Table 118. Johnson & Johnson Ibrutinib Product Offered

Table 119. Johnson & Johnson Ibrutinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 120. Johnson & Johnson Main Business

Table 121. Johnson & Johnson Latest Developments

List of Figures

Figure 1. Picture of Ibrutinib

Figure 2. Ibrutinib Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Ibrutinib Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Ibrutinib Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Ibrutinib Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 90 Capsules/Box

Figure 10. Product Picture of 120 Capsules/Box

Figure 11. Global Ibrutinib Sales Market Share by Type in 2021

Figure 12. Global Ibrutinib Revenue Market Share by Type (2017-2022)

Figure 13. Ibrutinib Consumed in Mantle Cell Lymphoma

Figure 14. Global Ibrutinib Market: Mantle Cell Lymphoma (2017-2022) & (K Pcs)

Figure 15. Ibrutinib Consumed in Chronic Lymphocytic Leukemia

Figure 16. Global Ibrutinib Market: Chronic Lymphocytic Leukemia (2017-2022) & (K Pcs)

Figure 17. Ibrutinib Consumed in Small Lymphocytic Lymphoma

Figure 18. Global Ibrutinib Market: Small Lymphocytic Lymphoma (2017-2022) & (K Pcs)

Figure 19. Ibrutinib Consumed in Other

Figure 20. Global Ibrutinib Market: Other (2017-2022) & (K Pcs)

Figure 21. Global Ibrutinib Sales Market Share by Application (2017-2022)

Figure 22. Global Ibrutinib Revenue Market Share by Application in 2021

Figure 23. Ibrutinib Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Ibrutinib Revenue Market Share by Company in 2021

Figure 25. Global Ibrutinib Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Ibrutinib Revenue Market Share by Geographic Region in 2021

Figure 27. Global Ibrutinib Sales Market Share by Region (2017-2022)

Figure 28. Global Ibrutinib Revenue Market Share by Country/Region in 2021

Figure 29. Americas Ibrutinib Sales 2017-2022 (K Pcs)

Figure 30. Americas Ibrutinib Revenue 2017-2022 ($ Millions)

Figure 31. APAC Ibrutinib Sales 2017-2022 (K Pcs)

Figure 32. APAC Ibrutinib Revenue 2017-2022 ($ Millions)

Figure 33. Europe Ibrutinib Sales 2017-2022 (K Pcs)

Figure 34. Europe Ibrutinib Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Ibrutinib Sales 2017-2022 (K Pcs)

Figure 36. Middle East & Africa Ibrutinib Revenue 2017-2022 ($ Millions)

Figure 37. Americas Ibrutinib Sales Market Share by Country in 2021

Figure 38. Americas Ibrutinib Revenue Market Share by Country in 2021

Figure 39. United States Ibrutinib Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Ibrutinib Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Ibrutinib Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Ibrutinib Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Ibrutinib Sales Market Share by Region in 2021

Figure 44. APAC Ibrutinib Revenue Market Share by Regions in 2021

Figure 45. China Ibrutinib Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Ibrutinib Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Ibrutinib Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Ibrutinib Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Ibrutinib Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Ibrutinib Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Ibrutinib Sales Market Share by Country in 2021

Figure 52. Europe Ibrutinib Revenue Market Share by Country in 2021

Figure 53. Germany Ibrutinib Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Ibrutinib Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Ibrutinib Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Ibrutinib Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Ibrutinib Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Ibrutinib Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Ibrutinib Revenue Market Share by Country in 2021

Figure 60. Egypt Ibrutinib Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Ibrutinib Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Ibrutinib Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Ibrutinib Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Ibrutinib Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Ibrutinib in 2021

Figure 66. Manufacturing Process Analysis of Ibrutinib

Figure 67. Industry Chain Structure of Ibrutinib

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles